英文名称 | 中文名称 | CAS |
---|---|---|
BT2 | 3,6-二氯-2-苯并噻吩羧酸 | 34576-94-8 |
BEZ 235 - NVP-BEZ235 | NVP-BEZ235 | 915019-65-7 |
BAY 19-8004 - Lirimilast | LIRIMILAST | 329306-27-6 |
BTZ043 | 2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮 | 1161233-85-7 |
CMP5 | CMP5 | 1030021-40-9 |
BMS 232632 - Atazanavir | CGP 73547 | 阿扎那韦 | 198904-31-3 |
BEC hydrochloride - S-(2-Boronoethyl)-L-cysteine hydrochloride | BEC HCL, 一个竞争性的 ARGINASE II抑制剂 | 222638-67-7 |
Blebbistatin, (±)- | (+/-)-BLEBBISTATIN | 674289-55-5 |
BVT 2733 hydrochloride | CS-2111 | 376641-65-5 |
CHIR 99021 - CT 99021 | CHIR-99021 | 252917-06-9 |
BI-D1870 | BI-D1870 | 501437-28-1 |
BI 6727 - Volasertib | N-[反式-4-[4-(环丙基甲基)-1-哌嗪基]环己基]-4-[[(7R)-7-乙基-5,6,7,8-四氢-5-甲基-8-异丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺 | 755038-65-4 |
Butabindide oxalate | [S-(R*,R*)]-1-(2-氨基-1-氧代丁基)-N-丁基-2,3-二氢-1H-吲哚-2-甲酰胺草酸盐 | 185213-03-0 |
CGP 77675 | CGP 77675; CGP-77675 | 234772-64-6 |
CC-930 - Tanzisertib | TANZISERTIB | 899805-25-5 |
BCI hydrochloride - NSC 150117 hydrochloride | (E/Z)-BCI HYDROCHLORIDE | 95130-23-7 |
CM-272 | 化合物CM-272 | 1846570-31-7 |
CDDO-Me - Bardoxolone methyl | RTA 402 | 甲基巴多索隆 | 218600-53-4 |
CID 755673 | 2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one | 521937-07-5 |
BMS 582949 | BMS 582949 | 623152-17-0 |
AZD 2858 hydrochloride | 486424-21-9 | |
Biotinyl-phenylboronic acid | ||
BMS 345541 | N-(1,8-二甲基咪唑并[1,2-A]喹喔啉-4-基)-1,2-乙二胺盐酸盐 | 547757-23-3 |
BIRB 796 - BIRB 0796 | Doramapimod | 1-[2-(4-甲基苯基)-5-叔丁基吡唑-3-基]-3-[4-(2-吗啉-4-基乙氧基)萘-1-基]脲 | 285983-48-4 |
BI 2536 | BI 2536 | 755038-02-9 |
CHIR 98014 - CT 98014 | CHIR98014(CT98014) | 252935-94-7 |
CAL 101 - Idelalisib | 艾代拉里斯 | 870281-82-6 |
CHIR 124 | 4-[((3S)-1-氮杂双环[2,2,2]辛-3-基)氨基]-3-(1H-苯并咪唑-2-基)-6-氯喹啉-2(1H)-酮 | 405168-58-3 |
BMS 303141 | BMS303141 | 943962-47-8 |
BAY 58-2667 hydrochloride - Cinaciguat hydrochloride | 646995-35-9 | 646995-35-9 |
BAY 1895344 | BAY-1895344 | 1876467-74-1 |
CAIX Inhibitor S4 | CAIX Inhibitor S4 | 1330061-67-0 |
Brassinin | 芸苔宁 | 105748-59-2 |
BIX 01294 trihydrochloride | BIX 01294 | 935693-62-2 |
BX 795 | N-[3-[[5-碘-4-[[3-[(2-噻吩基羰基)氨基]丙基]氨基]-2-嘧啶基]氨基]苯基]-1-吡咯烷甲酰胺 | 702675-74-9 |
BZ, γ-Secretase Inhibitor - Compound E | N-[(1S)-2-[[(3S)-2,3-二氢-1-甲基-2-氧代-5-苯基-1H-1,4-苯并二氮杂卓-3-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟苯乙酰胺 | 209986-17-4 |
CID 2011756 | CID-2011756 | 638156-11-3 |
Brigatinib - AP 26113 | Alunbrig | 布格替尼 | 1197953-54-0 |
CDIBA | 479422-22-5 | |
AZD2716 | AZD2716 | 1845753-81-2 |
Clindamycin - Dalacine | U 21251 | 克林霉素 | 18323-44-9 |
CHIR 99021 dihydrochloride - CT 99021 dihydrochloride | ||
BIX 02189 | 3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯基亚甲基]-2,3-二氢-N,N-二甲基-2-氧代-1H-吲哚-6-甲酰胺 | 1094614-85-3 |
Bizine | BIZINE | 1591932-50-1 |
CHR 6494 trifluoroacetate | CHR 6494 trifluoroacetate | 1458630-17-5 |
CCT251236 | CCT251236 | 1693731-40-6 |
BIO - GSK-3 inhibitor IX | 6-Bromoindirubin-3'-oxime | (2'Z,3'E)-6-溴靛玉红-3'-肟 | 667463-62-9 |
BTB 1 - NSC 156750 | NSC 658180 | 4-氯-2-甲基苯基硫氰酸酯 | 86030-08-2 |
CI 994 - PD 123654 | Tacedinaline | 4-乙酰氨基-N-(2'-氨基苯基)-苯甲酰胺 | 112522-64-2 |
AZD 5438 | 4-[2-甲基-1-异丙基-1H-咪唑-5-基]-N-[4-(甲磺酰基)苯基]-2-嘧啶胺 | 602306-29-6 |
Balicatib - AAE 581 | BALICATIB | 354813-19-7 |
BIBR 1532 | 2-[[(2E)-3-(2-萘基)-1-氧代-2-丁烯基]氨基]苯甲酸 | 321674-73-1 |
CNF 2024 - BIIB 021 | BIIB021/CNF2024 | 848695-25-0 |
C 646 | C646 | 328968-36-1 |
CHIR 090 | CHIR 090 | 728865-23-4 |
BCI - NSC 150117 | BCI | 1245792-51-1 |
AZD 5363 dihydrochloride - Capivasertib | 2108875-84-7 | 2108875-84-7 |
CGP 57380 | N3-(4-氟苯基)-1H-吡唑并[3,4-D]嘧啶-3,4-二胺 | 522629-08-9 |
AZD 7762 hydrochloride | 3-[(氨基羰基)氨基]-5-(3-氟苯基)-N-(3S)-3-哌啶基-2-噻吩羧胺 | 860352-01-8 |
AZD 6482 - KIN-193 | 2-[[(1R)-1-[7-甲基-2-(4-吗啉)-4-氧代-4H-吡啶并[1,2-A]嘧啶-9-基]乙基]氨基]苯甲酸 | 1173900-33-8 |
Begacestat - GSI 953 | BEGACESTAT | 769169-27-9 |
CCT 137690 | 甲磺酸阿贝西尼 | 1095382-05-0 |
CID 1067700 | 2-[[(苯甲酰基氨基)硫代甲酰]氨基]-4,7-二氢-5,5-二甲基-5H-噻吩并[2,3-C]吡喃-3-羧酸 | 314042-01-8 |
BQR695 - NVP-BQR695 | BQR695 | 1513879-21-4 |
BAY-598 | BAY-598(S-isomer) | 1906919-67-2 |
Celecoxib - SC 58635 | Celebrex | Celebra | 塞来昔布 | 169590-42-5 |
Compound 120 - Atazanavir, deuterated | CTP 518 | ||
AZD 6244 - ARRY 142886 | Selumetinib | 司美替尼 | 606143-52-6 |
CC-401 | 3-[3-[2-(1-哌啶基)乙氧基]苯基]-5-(1H-1,2,4-三唑-5-基)-1H-吲唑 | 395104-30-0 |
AZD 8055 | AZD8055 | 1009298-09-2 |
AZD 8330 | 2-(2-氟-4-碘苯氨基)-N-(2-羟基乙氧基)-1,5-二甲基-6-氧代-1,6-二氢吡啶-3-甲酰胺 | 869357-68-6 |
CGI 1746 | N-[3-[4,5-二氢-4-甲基-6-[[4-(4-吗啉基羰基)苯基]氨基]-5-氧代-2-吡嗪基]-2-甲基苯基]-4-(叔丁基)苯甲酰胺 | 910232-84-7 |
CID 5951923 | CID 5951923 | 749872-43-3 |
Baricitinib - INCB 028050 | LY 3009104 | 巴瑞克替尼 | 1187594-09-7 |
BIX 02188 | (3Z)-3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯基亚甲基]-2,3-二氢-N-甲基-2-氧代-1H-吲哚-6-甲酰胺 | 334951-92-7 |
BAY 57-1293 - Pritelivir | AIC 316 | 普瑞利韦 | 348086-71-5 |
CCG 50014 | L 2-401 | 883050-24-6 |
Cerdulatinib - PRT 062070 | 赛度替尼 | 1198300-79-6 |
BMH 21 | BMH-21 | 896705-16-1 |
BRD 73954 | BRD73954 | 1440209-96-0 |
BQU 57 | BQU57 | 1637739-82-2 |
CK2 inhibitor 10 | CK2 inhibitor 10 | 1361229-76-6 |
BCI-121 | BCI-121 | 432529-82-3 |
Azithromycin - CP 62993 | Zithromax | 阿奇霉素二水物 | 117772-70-0 |
CCG 232601 | CCG-232601 | 1922099-21-5 |
BAY-678 | 化合物 T10473 | 675103-36-3 |
Bortezomib - PS 341 | 硼替佐米 | 179324-69-7 |
BACE-1 Inhibitor | BETA-SECRETASE INHIBITOR IV | 797035-11-1 |
Cambinol - NSC 112546 | SIRT1/2 INHIBITOR IV | 14513-15-6 |
BX 912 | BX-912 | 702674-56-4 |
BAG 956 - NVP-BAG956 | 2-甲基-2-[4-[2-甲基-8-[(吡啶-3-基)乙炔基]咪唑并[4,5-C]喹啉-1-基]苯基]丙腈 | 853910-02-8 |
CK 1827452 - Omecamtiv Mecarbil | CK-452 | 4-[[2-氟-3-[N'-(6-甲基吡啶-3-基)脲基]苯基]甲基]哌嗪-1-羧酸甲酯 | 873697-71-3 |
CCT 007093 | (2E,5E)-2,5-二(2-噻吩基亚甲基)环戊酮 | 176957-55-4 |
CDN1163 | 4-异丙氧基-N-(2-甲基喹啉-8-基)苯甲酰胺 | 892711-75-0 |
CBR 5884 | CBR-5884 | 681159-27-3 |
BFF 122 - BF 5 | BFF 122 | 1152314-49-2 |
Boc-D-FMK - Boc-Asp(OMe)-fluoromethyl ketone | BAF | (3S)-3-[[叔丁氧羰基]氨基]-5-氟-4-氧代-戊酸甲酯 | 187389-53-3 |
COH000 | (1R,4S)-二甲基1-((R)-1-(苯基氨基)-2-(对甲苯基)乙基)-7-氧杂二环[2.2.1]庚-2,5-二烯-2,3-二羧酸 | 1534358-79-6 |
C 7280948 | C7280948 | 587850-67-7 |
BAY 11-7082 - BAY 11-7821 | (E)-3-(P-TOLUENESULFONYL)ACRYLONITRILE | 19542-67-7 |
联系方式
电话:703 - 9861
邮箱:info@axonmedchem.com
网址: http://www.axonmedchem.com
产品总数: 763
CB指数:58
国籍:美国